We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Sandoz Group AG (SDZ) CHF0.05

Sell:39.86 CHF Buy:39.87 CHF Change: 0.14 CHF (0.35%)
Market closed |  Prices as at close on 20 November 2024 | Switch to live prices |
Sell:39.86 CHF
Buy:39.87 CHF
Change: 0.14 CHF (0.35%)
Market closed |  Prices as at close on 20 November 2024 | Switch to live prices |
Sell:39.86 CHF
Buy:39.87 CHF
Change: 0.14 CHF (0.35%)
Market closed |  Prices as at close on 20 November 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Sandoz Group AG is a Switzerland based company which is active in healthcare technology industry. The Company operates in two businesses, Generics and Biosimilars. Generics business develops, manufacture and market active ingredients and finished dosage forms of small molecule pharmaceuticals, finished dosage forms of anti-infectives and active pharmaceutical ingredients and intermediates. Biosimilars business develops, manufacture and market protein-based and other biological products which are similar to another already approved biological medicines. Company’s product portfolio comprising Generics and Biosimilars covers all therapeutic areas for patient treatment such as cardiovascular, central nervous system, oncology, anti-infectives, pain and respiratory. The Company serves customers worldwide.

Contact details

Address:
Suurstoffi 14
ROTKREUZ
6343
Switzerland
Telephone:
+ ()
Website:
https://www.sandoz.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
SDZ
ISIN:
CH1243598427
Market cap:
17.47 billion CHF
Shares in issue:
438.93 million
Sector:
Pharmaceuticals
Exchange:
SIX Swiss Exchange
Country:
Switzerland
Currency:
Swiss Franc
Indices:
Swiss All Share Index

Key personnel

  • Richard Saynor
    Chief Executive Officer
  • Remco Steenbergen
    Chief Financial Officer
  • Francisco Ballester
    President, International
  • Rebecca Guntern
    President, Europe
  • Keren Haruvi
    President, North America
  • Claire D'Abreu-Hayling
    Chief Scientific Officer
  • Ingrid Sollerer
    Chief Compliance Officer, Group General Counsel
  • Pierre Bourdage
    Chief Commercial Officer
  • Glenn Gerecke
    Chief Manufacturing and Supply Officer
  • Tripti Jha
    Chief People Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.